ESR1 and breast carcinoma: Compared with estrogen receptor-positive and human epidermal growthfactor receptor 2 (HER2) breast cancer, TNBC contained more PC (32:1) and PC (30:0) [130], suggesting the potential of phospholipids as candidate predictors [42,91].